FIELD: organic chemistry, heterocyclic compounds, purines, medicine.
SUBSTANCE: invention relates to a method for treatment of arrhythmia in mammal. Method involves administration of agonist of adenosine A1-receptors in the therapeutically effective minimal dose of the formula:
wherein R1 represents optionally substituted heterocyclic group. The indicated dose of agonist is in the range from 0.0003 to 0.009 mg/kg. Method shows the enhanced effectiveness and doesn't result to undesirable adverse effects.
EFFECT: improved treatment method, valuable medicinal properties of substances.
11 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF HEARTBEAT FREQUENCY REDUCTION INCLUDING ADMINISTRATION OF ADENOSINE A RECEPTOR AGONIST TOGETHER WITH BETA-BLOCKER, CALCIUM CANAL BLOCKER OR CARDIAC GLYCOSIDE | 2003 |
|
RU2332220C2 |
| PARTIAL AND COMPLETE AGONISTS OF ADENOSINE A RECEPTORS | 2003 |
|
RU2317994C2 |
| DERIVATIVES OF ADENOSINE, PHARMACEUTICAL COMPOSITION AND METHOD OF CORRECTION OF ELECTRIC DISORDER IN MAMMAL HEART | 1997 |
|
RU2172320C2 |
| PARTIAL AND FULL AGONISTS OF ADENOSINE RECEPTORS A | 2003 |
|
RU2340623C2 |
| METHODS AND COMPOSITIONS IMPROVING PATIENT'S TOLERANCE OF MYOCARDIAL VISUALISATION TECHNIQUE | 2007 |
|
RU2459626C2 |
| AGONISTS OF ADENOSINE A3-RECEPTORS | 2002 |
|
RU2298557C2 |
| PRODRUG OF ADENOSINE A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415858C2 |
| BENZOFURAN DERIVATIVES, COMPOSITIONS BASED ON SAID DERIVATIVES AND METHODS OF TREATING CARDIAC ARRHYTHMIA | 2005 |
|
RU2373199C2 |
| USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS | 2010 |
|
RU2600869C2 |
| METHOD OF PREVENTION AND TREATMENT OF LIVER DISEASE WITH APPLICATION OF RECEPTOR A ANTAGONISTS | 2007 |
|
RU2457842C2 |
